1. Home
  2. AIMD

AIMD

Ainos Inc.

as 05-24-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form.

Founded: 1984 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 6.2M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 1.4M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.33 EPS Growth: N/A
52 Week Low/High: $0.79 - $6.10 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AIMD Daily Stock ML Predictions

Share on Social Networks: